previous compound ID: 82 next compound
InChIKey: XUIIKFGFIJCVMT-LBPRGKRZSA-N
SMILES: C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)C[C@@H](C(=O)O)N

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"DY Thomas" "D Rotin" "J Goepp" "JW Hanrahan" "J Liao" "B Kus" "GW Carlile" "SD Macknight" "E Matthes" "R Robert"

chemical graph of compound 82





CID is 5819
synonyms found at PubChem are:
L-thyroxine, levothyroxine, 51-48-9, thyroxine, thyroxin, synthroid, Tetraiodothyronine, Thyrax, 3,3',5,5'-Tetraiodo-L-thyronine, Thyratabs, Thyreoideum, Thyroxinal, Thyroxine iodine, Levothyroxin, (-)-Thyroxine, L-Thyroxin, L-T4, Thyroxine (l), Levothyroxine sodium, 3,5,3',5'-Tetraiodo-L-thyronine, levothroid, Levoxyl, DL-Thyroxin, Thyroxine (VAN), eltroxin, 3,5,3',5'-Tetraiodothyronine, Laevothyroxinum, Tetramet, T4 (Hormone), Thyroxine I 125, L-3,5,3',5'-Tetraiodothyronine, Levothyroxinum (acid), t4, Laevothyroxinum (acid), Thryroxine, l-, Oroxine, Levo-T, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine, Forthyron (TN), Thyroxine [BAN], Laevoxin, Levolet, Levothyrox, Thyroxevan, Synthroid sodium, Levothyroxinum, O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodotyrosine, 3,3',5,5''-Tetraiodo-L-thyronine, CCRIS 6739, Henning, HSDB 3108, L-Thryoxin, T4 levothyroxine, 3,5,3'5'-Tetraiodo-L-thyronine, THX, UNII-Q51BO43MG4, NSC 36397, Prestwick_548, 4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodo-L-phenylalanine, Levothyroxine (BAN), Thyroxine sodium, CHEBI:18332, O-(4-Hydroxy-3,5-diidophenyl)-3,5-diiodo-L-tyrosine, L-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, EINECS 200-101-1, 3-(4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)alanine, beta-((3,5-Diiodo-4-hydroxyphenoxy)-3,5-diiodophenyl)alanine, 3-[4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]-L-alanine, Synthroid (*Sodium salt*), BRN 2228515, CHEMBL1624, (125I)T4, (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid, Q51BO43MG4, UNII-7U4LEE5872, XUIIKFGFIJCVMT-LBPRGKRZSA-N, Levothyroxine Sodium (L-thyroxine), C15H11I4NO4, NCGC00164336-01, CPD000059176, Synthroid (TN), Levoxyl (TN), DSSTox_CID_3214, T-3850, (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]propanoic acid, DSSTox_RID_76927, DSSTox_GSID_23214, Eutirox, Thyroxine, L-, 7U4LEE5872, levothyroxine sodium pentahydrate, (S)-2-amino-3-(4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)propanoic acid, 2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]-propanoic acid, LT4, SMR000059176, T44, 24486-40-6, 7488-70-2, Levothyroxine [INN:BAN], Forthyron, SR-01000759430, 2ceo, CAS-51-48-9, Eltroxin (TN), Euthyrox (TN), levothyroxin natrium, Eutirox (TN), Levaxin (TN), Thyroxine, labeled with iodine-125, L-thyroxine (TN), Thyrax (TN), Thyrox (TN), Spectrum_001076, 1hk1, 1hk2, 1hk3, 1hk4, 1hk5, 1y0x, L-Thyroxine, free acid, SpecPlus_000871, Thyroxine, L-(8CI), Prestwick0_000403, Prestwick1_000403, Prestwick2_000403, Prestwick3_000403, Spectrum2_000573, Spectrum3_000611, Spectrum4_000128, Spectrum5_001500, Thyroxine, L- (8CI), bmse000923, D06RGG, Epitope ID:123889, Levothroid (*Sodiumsalt*), AC1L1L7K, BIDD:PXR0161, Levothroid (*Sodium salt*), SCHEMBL23098, BSPBio_000326, BSPBio_002142, KBioGR_000516, KBioSS_001556, MLS000028647, MLS002548901, DivK1c_006967, SPECTRUM1500774, SPBio_000386, SPBio_002265, BPBio1_000360, GTPL2635, DTXSID8023214, CTK2H7538, KBio1_001911, KBio2_001556, KBio2_004124, KBio2_006692, KBio3_001642, KS-00000HDI, MolPort-003-666-820, HMS1569A08, HMS1921I06, HMS2090P18, HMS2092K12, HMS2096A08, HMS2233J18, HMS3259M11, HMS3713A08, L-Thyroxine, >=98% (HPLC), Pharmakon1600-01500774, ZINC3830993, Tox21_112101, Tox21_302156, 3,3',5,5"-Tetraiodo-L-thyronine, BDBM50301375, CCG-38738, CT-230, GP9966, MFCD00002595, NSC757434, s2599, AKOS015905129, Tox21_112101_1, AC-7504, AM83594, AN-8921, CHM0030272, CS-1819, DB00451, NC00485, NSC-757434, SDCCGMLS-0066571.P001, 3,3'',5,5''-tetraiodo-L-thyronine, 3,5,3'',5''-tetraiodo-L-thyronine, NCGC00094852-03, NCGC00164336-02, NCGC00164336-03, NCGC00164336-05, NCGC00164336-06, NCGC00255368-01, AC-10465, AK-40208, AN-15421, BC630681, HY-18341, KB-53412, SAM002264651, SBI-0051608.P002, AB0010528, AB2000689, AX8015809, DB-006261, LS-158291, TR-031344, FT-0600821, LT00440967, ST24047479, C01829, D08125, J10324, AB00052176-08, AB00052176_09, AB00052176_10, 002T595, SR-05000001567, SR-01000759430-2, SR-05000001567-1, BRD-K30685142-001-05-5, BRD-K30685142-001-08-9, Thyroxine (T4), IRMM(R) certified Reference Material, L-Thyroxine, powder, BioReagent, suitable for cell culture, UNII-QR0BV3BRIA component XUIIKFGFIJCVMT-LBPRGKRZSA-N, Levothyroxine, United States Pharmacopeia (USP) Reference Standard, Levothyroxine, Pharmaceutical Secondary Standard; Certified Reference Material, Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, labeled with iodine-125, 1373931-44-2, 587-29-1, 587-30-4, 60833-83-2, 7200-84-2, 74-16-8, L-Thyroxine (T4) solution, 100 mug/mL in methanol with 0.1N NH3, ampule of 1 mL, certified reference material, L-thyroxine zwitterion, CHEBI:58448, (2S)-2-ammonio-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoate